Sharechat Logo

NZX Limited (NZX: NZX) Statement on FMA Market Operator Obligations Report

Thursday 28th January 2021

Text too small?

NZX has closely reviewed the Financial Markets Authority (FMA) report, Market Operator Obligations Targeted Review – NZX, and acknowledges the FMA's conclusions that, in certain respects, NZX breached its market operator obligations in relation to its technology resources.

NZX Chief Executive, Mr Mark Peterson said NZX takes its market operator obligations extremely seriously. “We acknowledge the issues that have affected our technology platforms and market participants in 2020.”

“NZX accepts that it did not meet the high standards it sets for itself in key areas of technology resources. We also agree that improvements are required and we are committed to delivering these improvements via an action plan that will be agreed with the FMA. We will work constructively with the FMA through that process and engage closely with the broader capital markets technology ecosystem,” he said.

Please see the link below for more details:

NZX statement on FMA Market Operator Obligations Report

Source: NZX Limited



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

19th January 2022 Morning Report
PaySauce Limited (NZX: PYS) Quarterly Market Update Dec 2021
FTX announced as naming rights sponsor of Australian Blockchain Week 2022
18th January 2022 Morning Report
17th January 2022 Morning Report
Mosaic lands leading corporate trust expert as new partner
14th January 2022 Morning Report
13th January 2022 Morning Report
Pictor's completes successful US clinical trials for unique COVID antibody testing
12th January 2022 Morning Report